# Compliance Agent Review — FSL Command Center
## Capture Date: 2026-05-12
## Review Date: 2026-05-10
## Reviewer: Compliance Agent (6-Agent Academic Review)

---

## VERDICT: CONDITIONAL PASS — 4 CRITICAL GAPS, 3 LEXICON VIOLATIONS

The Command Center surfaces patent notice and Phase 1 disclosure correctly but is missing trademark identification entirely, contains no HIPAA framing language, has no regulatory disclaimers visible in the rendered page, omits non-provisional patent deadline tracking, and violates FSL lexicon rules in multiple agent responsibility descriptions.

---

## 1. MISSING ELEMENTS

### 1.1 Trademark 99533250 — MISSING ENTIRELY
- Zero occurrences of "99533250" anywhere in the captured HTML.
- No trademark notice, TM symbol, or registration reference appears in the footer, header, or any card.
- **Remediation:** Add `Trademark — U.S. Serial No. 99,533,250` to the footer alongside the patent notice, or create a dedicated IP card.

### 1.2 HIPAA Framing — MISSING ENTIRELY
- The word "HIPAA" does not appear anywhere in the Command Center content.
- No "outside scope" disclaimer is present. No "compliant" claim either (which would be worse), but the absence of any framing is a gap.
- **Remediation:** Add a visible statement such as: "HIPAA compliance is outside the scope of this Phase 1 demonstration. FSL operates as a sovereign health governance platform, not a covered entity." Place in a regulatory disclaimer card or footer block.

### 1.3 Non-Provisional Patent Deadline (May 2027) — NOT TRACKED
- The footer states "Patent Pending — U.S. Provisional Application No. 64/063,037" (correct).
- However, the Progress Tracker (19-step build) contains no milestone for the non-provisional filing deadline (May 2027).
- No date or countdown is visible anywhere for this critical IP deadline.
- **Remediation:** Add a tracked milestone or deadline indicator: "Non-Provisional Filing Deadline: May 2027" in either the Progress Tracker or a dedicated IP/Legal card.

### 1.4 Practitioner Acknowledgments — NOT ACCESSIBLE
- Zero occurrences of "practitioner," "acknowledgment," or "acknowledge" in the captured content.
- No link, modal, or section references a practitioner acknowledgment flow or document.
- **Remediation:** If practitioner acknowledgments exist elsewhere in the ecosystem, add a link or reference from the Command Center. If they do not yet exist, flag for creation.

### 1.5 Regulatory Disclaimers — NOT VISIBLE IN RENDERED PAGE
- The footer contains only: "FSL . Future Systems Lab . Where Mental Wellness Meets Metaverse . Rights Reserved, Unlicensed" plus the patent line.
- No educational-purpose disclaimer, no "not medical advice" notice, no "for demonstration purposes only" language appears in the visible HTML.
- The Compliance agent definition (in JavaScript) references "educational disclaimer compliance" but this is metadata about the agent, not a user-facing disclaimer.
- **Remediation:** Add a visible regulatory disclaimer block. Recommended language: "This platform is an educational technology demonstration. It does not provide medical advice, diagnosis, or treatment. Content is for informational and research purposes only."

---

## 2. PRESENT BUT BROKEN

### 2.1 Phase 1 Demonstration Disclosure — PARTIAL
- Phase 1 is labeled "Phase 1 — Foundation" in the Progress Tracker (line 850).
- The tracker shows 2/19 steps complete with a progress bar at 18%.
- Step 16 is labeled "Demo" with subtitle "End-to-end walkthrough . DEng applied project documentation."
- **Issue:** There is no explicit "Phase 1 demonstration" disclosure statement visible to users. The build tracker shows progress phases but does not affirmatively state that the current deployment is a Phase 1 demonstration/prototype. A visitor could interpret the LIVE badges on HypnoNeuro, ClaimChain, and AlchemistForge as production-ready systems.
- **Remediation:** Add a banner or card-level notice: "Current Status: Phase 1 Demonstration — Sepolia Testnet Only — Not Production."

### 2.2 Patent Notice — PRESENT BUT LOW VISIBILITY
- Patent 64/063,037 appears once in the footer (line 1195) with `font-size:10px;color:#ffffff22` — that is white text at ~13% opacity on a dark background.
- This is functionally invisible. A reasonable user would not see it.
- **Remediation:** Increase opacity to at least `#ffffff88` or move to a dedicated IP section.

---

## 3. FSL LEXICON VIOLATIONS

### 3.1 "patient" — VIOLATION (2 occurrences)
- Line 1278: `'Ensures no placeholder IDs — real patient/provider records tracked'` (Database agent responsibilities)
- Line 1289: `'Reviews all patient-facing copy for educational disclaimer compliance'` (Compliance agent responsibilities)
- Per FSL lexicon rules, "patient" is prohibited. Use "participant," "individual," or "user."

### 3.2 "provider" — VIOLATION (1 occurrence)
- Line 1278: `'Ensures no placeholder IDs — real patient/provider records tracked'`
- Per the Sovereign Guides policy (MEMORY.md), all user-facing "Providers" copy must read "Sovereign Guides." Internal route/variable/DB names may remain unchanged, but visible text must use the updated term.

### 3.3 "ClaimChain" — PRESENT (multiple occurrences)
- "ClaimChain" appears in card titles, subtitles, contract registry, agent responsibilities, and timeline items.
- **Assessment:** Per the review checklist, "ClaimChain" was flagged for lexicon review. The term appears throughout as a product/contract name (e.g., "ClaimChain Sovereign Governance"). If the intent is to retire this term from user-facing copy, it requires a sweep of: lines 775, 776, 892, 1040, 1061, 1120, 1122, 1216, 1266, 1277, 1279, 1290.
- **Note:** If "ClaimChain" remains an approved product name (only the internal claim-processing connotation is prohibited), then these usages are acceptable. Clarify policy intent.

---

## 4. DOMAIN-SPECIFIC FINDINGS

### 4.1 "Sovereign Health Governance" Framing — GOOD
- ClaimChain is consistently described as "Sovereign Health Governance" (line 776 card subtitle, line 1062, line 1122, line 1290).
- The Compliance agent responsibility explicitly states: "Maintains ClaimChain as sovereign health governance (not medical/insurance)" (line 1290).
- This framing correctly distances FSL from insurance/medical-claims language.

### 4.2 Neurotransmitter-Based Protocol Framing — GOOD
- HypnoNeuro games reference GABA, Serotonin, Dopamine, Oxytocin, and Endocannabinoid systems.
- No diagnostic labels (e.g., "anxiety," "depression," "PTSD") appear in the Command Center content.
- The Compliance agent explicitly states: "Frames all health protocols around neurotransmitter systems, not diagnoses" (line 1288).

### 4.3 Testnet-Only Deployment — CORRECT
- All contract addresses point to `eth-sepolia.blockscout.com`.
- The Contract Registry card is labeled "Sepolia Testnet."
- No mainnet addresses or mainnet claims are present.

### 4.4 Rights Reserved, Unlicensed — PRESENT
- Footer includes "Rights Reserved, Unlicensed" (line 1195).
- Security agent responsibility confirms this is enforced on all code files (line 1300).

### 4.5 Agent Council Compliance Role — PRESENT BUT INCOMPLETE
- A dedicated Compliance agent exists in the 12-agent council with relevant skills (Digital Health Compliance, Web3 Governance, FHIR, Sovereign Health Law, Disclaimer Language).
- However, its own responsibility text uses prohibited lexicon ("patient-facing" at line 1289), undermining credibility.

---

## SUMMARY TABLE

| Check Item | Status | Severity |
|---|---|---|
| Patent 64/063,037 visible | PRESENT but near-invisible (13% opacity) | MEDIUM |
| Trademark 99533250 visible | MISSING | CRITICAL |
| HIPAA "outside scope" framing | MISSING | CRITICAL |
| FSL lexicon (no "patient") | VIOLATED — 2 occurrences | HIGH |
| FSL lexicon (no "provider") | VIOLATED — 1 occurrence | HIGH |
| FSL lexicon (no "ClaimChain") | PRESENT — policy ambiguous | MEDIUM |
| Phase 1 demonstration disclosure | PARTIAL — no explicit statement | HIGH |
| Practitioner acknowledgments accessible | MISSING | CRITICAL |
| Non-provisional deadline May 2027 tracked | MISSING | CRITICAL |
| Regulatory disclaimers present | MISSING | CRITICAL |
| Sovereign governance framing | CORRECT | PASS |
| Neurotransmitter (not diagnostic) framing | CORRECT | PASS |
| Testnet-only (no mainnet claims) | CORRECT | PASS |

---

## RECOMMENDED PRIORITY ACTIONS

1. **IMMEDIATE** — Add trademark 99533250 to footer or IP section.
2. **IMMEDIATE** — Add HIPAA "outside scope" disclaimer with correct framing.
3. **IMMEDIATE** — Add visible regulatory/educational disclaimer block.
4. **IMMEDIATE** — Track non-provisional patent deadline (May 2027) in Progress Tracker or dedicated card.
5. **HIGH** — Replace "patient" with "participant" and "provider" with "Sovereign Guide" in all user-facing agent descriptions.
6. **HIGH** — Add explicit Phase 1 demonstration disclosure banner.
7. **MEDIUM** — Increase patent notice opacity from #ffffff22 to at least #ffffff88.
8. **MEDIUM** — Add practitioner acknowledgment link or section.
9. **LOW** — Clarify ClaimChain lexicon policy and sweep if retirement is intended.
